ACA vs ECG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 26, 2026

ACA

57.8
AI Score
VS
ECG Wins

ECG

58.6
AI Score

Investment Advisor Scores

ACA

58score
Recommendation
HOLD

ECG

59score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ACA ECG Winner
Revenue 1.23B 2.27B ECG
Net Income 366.30M 142.21M ACA
Gross Margin 22.5% 13.8% ACA
Net Margin 29.8% 6.3% ACA
Operating Income 131.40M 189.46M ECG
ROE 12.3% 18.4% ECG
ROA 6.9% 6.9% ECG
Total Assets 5.30B 2.06B ACA
Current Ratio 3.12 1.59 ACA

Relative Price Performance (Last 90 Days)

ACA 1M: +0.9% · 3M: +0.9% ECG 1M: +10.7% · 3M: -13.2%

Current Technical Phase

ACA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 65.1 · Price: $146.71

ECG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.0 · Price: $124.81

Fundamentals Snapshot

Metric ACA ECG
Market Cap — —
Forward P/E 28.6 19.9
Trailing P/E 32.6 23.6
Revenue (TTM) — —
Revenue Growth 0.0% 0.3%
Gross Margin 0.2% 0.1%
Operating Margin 0.1% 0.1%
EPS 4.48 4.98
Dividend Yield 0.00% —

Frequently Asked Questions

Based on our detailed analysis, ECG is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.